BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 8, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 2005

View Archived Issues

A phase I study reports antitumor activity for irofulven plus docetaxel

Read More

Peru-15 cholera vaccine found safe and immunogenic in adults and children

Read More

PTCA shows therapeutic potential for NASH

Read More

Promising results reported with a novel vaccine against Gram-positive bacteria

Read More

New data confirm the benefits of TH-070 in symptomatic BPH

Read More

Callisto reports plans for upcoming phase I/II ALL trial with annamycin

Read More

Callisto to evaluate atiprimod for treatment of myelodysplastic syndrome

Read More

NOX-B11: A novel ghrelin antagonist for obesity

Read More

Update on paricalcitol in the treatment of SHPT

Read More

DTwPHibHBV vaccine reported safe and immunogenic in humans

Read More

Phase II data on the effects of 4-OHT in cyclic mastalgia

Read More

Tanaproget shows efficacy as a novel contraceptive in healthy women

Read More

A drospirenone/ethinylestradiol combination shows promise in PMDD

Read More

Affitech enters licensing agreement for cancer-specific antibodies

Read More

NICE recommends use of Caelyx as second-line or subsequent treatment of advanced ovarian cancer

Read More

Par and Optimer enter development and collaboration agreement for PAR-101

Read More

Parent Project Muscular Dystrophy and Asklepios collaboration supports DMD gene therapy

Read More

Vitamin D3 analogue shows promise in a murine model of colitis-associated colon cancer

Read More

VistaGen Therapeutics receives NIH grant for preclinical studies of AV-101 for epilepsy

Read More

Inhaled insulin feasible and acceptable in patients with diabetes

Read More

Muraglitazar effective in randomized, double-blind trials in type 2 diabetes

Read More

Silodosin improves BPH symptoms in phase III trial

Read More

Recurrences unaffected by fenretinide in non-muscle invasive bladder cancer

Read More

Amitriptyline effective but limited by anticholinergic effects in interstitial cystitis

Read More

Novavax reports promising preclinical results with MNP technology

Read More

Patient enrollment in pivotal trial of Conor's CoStar drug-eluding stent commences

Read More

Norelin induces antitumor effects in patients with HDPC

Read More

Novel therapeutic agents for gastrointestinal disorders revealed in patents

Read More

Recent patents disclose novel analgesic agents

Read More

New therapeutics for cardiovascular diseases reported

Read More

GlaxoSmithKline submits BLA for Fluarix flu vaccine

Read More

Daiichi Suntory Pharma reports change in company name

Read More

Xenical receives positive opinion in E.U. for weight loss in adolescents

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 5, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 5, 2025.
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing